No 483 observations were issued
Jeevan Scientific Technology announced that the USFDA conducted an un-announced audit of its corporate and clinical pharmacology centre facilities. The purpose of this audit was to review the BA/BE studies. The auditor started the review on 05 June 2017 and completed on 08 June 2017. No 483 observations were issued.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
